Royal Bank of Canada
PRCT icon

Royal Bank of Canada’s Procept Biorobotics PRCT Stock Holding History

Royal Bank of Canada’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
53,538
+14,576
+37% +$365K ﹤0.01% 3701
2026
Q1 		$975K Buy
38,962
+24,375
+167% +$687K ﹤0.01% 3641
2025
Q4 		$460K Sell
14,587
-280,548
-95% -$9.3M ﹤0.01% 4230
2025
Q3 		$10.5M Buy
295,135
+82,620
+39% +$3.77M ﹤0.01% 2117
2025
Q2 		$12.2M Buy
212,515
+192,136
+943% +$10.9M ﹤0.01% 1876
2025
Q1 		$1.19M Sell
20,379
-6,499
-24% -$444K ﹤0.01% 3340
2024
Q4 		$2.16M Buy
26,878
+8,718
+48% +$745K ﹤0.01% 2973
2024
Q3 		$1.45M Buy
18,160
+4,726
+35% +$336K ﹤0.01% 3241
2024
Q2 		$820K Buy
13,434
+5,875
+78% +$349K ﹤0.01% 3622
2024
Q1 		$373K Sell
7,559
-4,736
-39% -$225K ﹤0.01% 4173
2023
Q4 		$515K Buy
12,295
+7,455
+154% +$254K ﹤0.01% 4237
2023
Q3 		$159K Buy
4,840
+1,290
+36% +$44K ﹤0.01% 5007
2023
Q2 		$125K Buy
3,550
+1,281
+56% +$42.4K ﹤0.01% 5151
2023
Q1 		$64K Sell
2,269
-1,126
-33% -$39.7K ﹤0.01% 5487
2022
Q4 		$141K Buy
3,395
+2,583
+318% +$111K ﹤0.01% 5189
2022
Q3 		$34K Buy
812
+168
+26% +$6.7K ﹤0.01% 5929
2022
Q2 		$21K Sell
644
-300
-32% -$10.9K ﹤0.01% 6090
2022
Q1 		$33K Sell
944
-1,062
-53% -$25.6K ﹤0.01% 6333
2021
Q4 		$50K Buy
2,006
+1,506
+301% +$55.7K ﹤0.01% 6372
2021
Q3 		$19K Buy
+500
New +$19.2K ﹤0.01% 6728

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royal Bank of Canada's PRCT Position: Q2 2026 in Review

Royal Bank of Canada increased its Procept Biorobotics (PRCT) stake by 37% in Q2 2026, buying an estimated $365K and bringing the position to 53,538 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #3701.

Royal Bank of Canada first reported a position in PRCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $12.2M in Q2 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Royal Bank of Canada held 53,538 shares of Procept Biorobotics worth $1.21M as of Q2 2026.
  • Royal Bank of Canada bought 14,576 Procept Biorobotics shares in Q2 2026, an estimated $365K.
  • Procept Biorobotics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #3701 holding.
  • Royal Bank of Canada first reported a position in Procept Biorobotics in Q3 2021 and has held it in 20 quarters since.
  • Royal Bank of Canada's Procept Biorobotics position peaked at $12.2M in Q2 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.